Prediction of miRNA interaction with mRNA of stroke candidate genes

  • Аida Kondybayeva
  • Aigul Akimniyazova
  • Saltanat Kamenova
  • Gulsum Duchshanova
  • Dana Aisina
  • Alla Goncharova
  • Аnatoliy IvashchenkoEmail author
Original Article



The role of miRNA in tissue affected by stroke is actively studied, but it remains unclear which miRNAs and target genes are involved in the development of stroke.


The MirTarget program defines the following features of a miRNA binding to a mRNA: the binding start site, the location of the binding site in mRNA, the free energy of a miRNA binding with a mRNA, and the interaction schemes of miRNA and mRNA.


The interaction of 6565 miRNAs with mRNAs of stroke candidate genes was determined. The association of the mRNAs of stroke candidate genes with miRNAs depends on the level of gene expression. Some highly expressed candidate genes are targets of miR-619-5p and miR-5095, which have binding sites located on overlapping mRNA nucleotide sequences (clusters). miR-619-5p and miR-5095 bind to mRNA of 15 genes. Clusters for the binding of miR-1273f,d,e are in mRNAs of highly expressed genes. The start sites of miR-1273d and miR-1273e binding in all clusters are in sequences with one and ten nucleotides, respectively. The clusters of multiple miR-574-5p and ID00470.5p-miR binding sites and the clusters of the miR-466, ID01030.3p-miR, and ID00436.3p-miR binding sites are in mRNAs of some genes expressed at low levels.


The organization of miRNA binding sites into clusters reduces the length of mRNA and creates competition between miRNAs for binding to mRNA of a target gene. The characteristics of miRNA associations with target genes can be used to recommend markers for a diagnosis of stroke.


Stroke miRNA mRNA Gene Expression 



We thank Pyrkova A.Yu, Niyazova R., Atambayeva Sh. for the help in the data analysis and interpretation and professor Natan M. Bornstein for advices in the writing of this article.

Funding information

This study was supported by a grant (AP05132460) from the Ministry of Education and Science, Kazakhstan Republic, SRI of Biology and Biotechnology Problems, al-Farabi Kazakh National University.

Compliance with ethical standards

Ethical Approval

Research involving Human Participants and/or Animals was not conducted.

Supplementary material

10072_2019_4158_MOESM1_ESM.pdf (273 kb)
ESM 1 (PDF 272 kb)
10072_2019_4158_MOESM2_ESM.pdf (414 kb)
ESM 2 (PDF 414 kb)


  1. 1.
    Deshpande RP, Panigrahi M, Chandrasekhar YBVK et al (2018) Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients. Neurol Sci 39:1895–1902. CrossRefPubMedGoogle Scholar
  2. 2.
    Caso V, de Sousa DA, Fischer U (2019) Status and perspectives of acute stroke care in Europe. Neurol Sci 40:1087–1088. CrossRefPubMedGoogle Scholar
  3. 3.
    Jin F, Xing J (2018) Circulating miR-126 and miR-130a levels correlate with lower disease risk, disease severity, and reduced inflammatory cytokine levels in acute ischemic stroke patients. Neurol Sci 39:1757–1765. CrossRefPubMedGoogle Scholar
  4. 4.
    Ding H, Gao S, Wang L, Wei Y, Zhang M (2019) Overexpression of miR-582-5p inhibits the apoptosis of neuronal cells after cerebral ischemic stroke through regulating PAR-1/Rho/Rho axis. J Stroke Cerebrovasc Dis 28:149–155. CrossRefPubMedGoogle Scholar
  5. 5.
    Jin F, Xing F (2017) Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity. Neurol Sci 38(11):2015–2023. CrossRefPubMedGoogle Scholar
  6. 6.
    Edwardson MA, Zhong X, Fiandaca MS, Federoff HJ, Cheema AK, Dromerick AW (2018) Plasma microRNA markers of upper limb recovery following human stroke. SciRep 8:12558. CrossRefGoogle Scholar
  7. 7.
    Tang Y, Zhao S, Wang J, Li D, Ren Q, Tang Y (2017) Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma. Neurol Sci 38(6):1087–1092. CrossRefPubMedGoogle Scholar
  8. 8.
    Zhang G, Chen L, Guo X, Wang H, Chen W, Wu G et al (2018) Comparative analysis of microRNA expression profiles of exosomes derived from normal and hypoxic preconditioning human neural stem cells by next generation sequencing. J Biomed Nanotechnol 14:1075–1089. CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang H, Wu J, Wu J, Fan Q, Zhou J, Wu J, Liu S, Zang J, Ye J, Xiao M, Tian T, Gao J (2019) Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnology 17:29. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Sun H, Zhong D, Wang C, Sun Y, Zhao J, Li G (2018) miR-298 exacerbates ischemia/reperfusion injury following ischemic stroke by targeting Act1. Cell Physiol Biochem 48:528–539. CrossRefPubMedGoogle Scholar
  11. 11.
    Xue WS, Wang N, Wang NY, Ying YF, Xu GH (2019) miR-145 protects the function of neuronal stem cells through targeting MAPK pathway in the treatment of cerebral ischemic stroke rat\. Brain Res Bull 144:28–38. CrossRefPubMedGoogle Scholar
  12. 12.
    Guo D, Ma J, Li T, Yan L (2018) Up-regulation of miR-122 protects against neuronal cell death in ischemic stroke through the heat shock protein 70-dependent NF-κB pathway by targeting FOXO3. Exp Cell Res 369:34–42. CrossRefPubMedGoogle Scholar
  13. 13.
    Lv H, Li J, Che YQ (2019) MicroRNA-150 contributes to ischemic stroke through its effect on cerebral cortical neuron survival and function by inhibiting ERK1/2 axis via Mal. J Cell Physiol 234:1477–1490. CrossRefPubMedGoogle Scholar
  14. 14.
    Nampoothiri SS, Rajanikant GK (2019) miR-9 upregulation integrates post-ischemic neuronal survival and regeneration in vitro. Cell Mol Neurobiol 39:223–240. CrossRefPubMedGoogle Scholar
  15. 15.
    Wan Y, Jin HJ, Zhu YY, Fang Z, Mao L, He Q et al (2018) MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes. FASEB J 32:3133–3148. CrossRefPubMedGoogle Scholar
  16. 16.
    Yao X, Wang Y, Zhang D (2018) microRNA-21 confers neuroprotection against cerebral ischemia-reperfusion injury and alleviates blood-brain barrier disruption in rats via the MAPK signaling pathway. J Mol Neurosci 65:43–53. CrossRefPubMedGoogle Scholar
  17. 17.
    Chen Z, Wang K, Huang J, Zheng G, Lv Y, Luo N, Liang M, Huang L (2018) Upregulated serum MiR-146b serves as a biomarker for acute ischemic stroke. Cell Physiol Biochem 45:397–405. CrossRefPubMedGoogle Scholar
  18. 18.
    Gui Y, Xu Z, Jin T, Zhang L, Chen L, Hong B, Xie F, Lv W, Hu XY (2018) Using extracellular circulating microRNAs to classify the etiological subtypes of ischemic stroke. Transl Stroke Res 10:352–361. CrossRefPubMedGoogle Scholar
  19. 19.
    Gao J, Yang S, Wang K, Zhong Q, Ma A, Pan X (2019) Plasma miR-126 and miR-143 as potential novel biomarkers for cerebral atherosclerosis. J Stroke Cerebrovasc Dis 28:38–43. CrossRefPubMedGoogle Scholar
  20. 20.
    Talebi A, Rahnema M, Bigdeli MR (2019) Effect of intravenous injection of antagomiR-1 on brain ischemia. Mol Biol Rep 46:1149–1155. CrossRefPubMedGoogle Scholar
  21. 21.
    Cheng HY, Wang YS, Hsu PY, Chen CY, Liao YC, Juo SH et al (2019) miR-195 has a potential to treat ischemic and hemorrhagic stroke through neurovascular protection and neurogenesis. Mol Ther Methods Clin Dev 13:121–132. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Jin F, Xing J (2018) Circulating miR-126 and miR-130a levels correlate with lower disease risk, disease severity, and reduced inflammatory cytokine levels in acute ischemic stroke patients. Neurol Sci 39(10):1757–1765 10.1007/s10072-018-3499-7CrossRefGoogle Scholar
  23. 23.
    Atambayeva S, Niyazova R, Ivashchenko A, Pyrkova A, Pinsky I, Akimniyazova A, Labeit S (2017) The binding sites of miR-619-5p in the mRNAs of human and orthologous genes. BMC Genomics 18:1–10. CrossRefGoogle Scholar
  24. 24.
    Kondybayeva АМ, Akimniyazova АN, Kamenova SU, Ivashchenko АТ (2018) The characteristics of miRNA binding sites in mRNA of ZFHX3 gene and its orthologs. Vavilov. J Genet Breed 22:438–444. CrossRefGoogle Scholar
  25. 25.
    Londin E, Loher P, Telonis AG, Quann K et al (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate and tissue-specific microRNAs. PNAS USA 112:1106–1115. CrossRefGoogle Scholar
  26. 26.
    Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621–628. CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ivashchenko AT, Pyrkova AY, Niyazova RY et al (2016) Prediction of miRNA binding sites in mRNA. Bioinformation 12:237–240CrossRefGoogle Scholar
  28. 28.
    Ivashchenko A, Berillo O, Pyrkova A (2014) Niyazova R (2014) binding sites of miR-1273 family on the mRNA of target genes. Biomed Res Int. Google Scholar
  29. 29.
    Moszyńska A, Gebert M, Collawn JF, Bartoszewski R (2017) SNPs in microRNA target sites and their potential role in human disease. Open Biol 7(4):1–13. CrossRefGoogle Scholar
  30. 30.
    Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) The properties of binding sites of miR-619-5p, miR-5095, miR-5096, and miR-5585-3p in the mRNAs of human genes. Biomed Res 2014:8. CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Join-Stock Company “National Medical University”AlmatyKazakhstan
  2. 2.SRI of Biology and Biotechnology Problemsal-Farabi Kazakh National UniversityAlmatyKazakhstan
  3. 3.Join-Stock Company “South Kazakhstan Medical Academy”ShymkentKazakhstan

Personalised recommendations